Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements

  1. Smith-Byrne, K.
  2. Cerani, A.
  3. Guida, F.
  4. Zhou, S.
  5. Agudo, A.
  6. Aleksandrova, K.
  7. Barricarte, A.
  8. Barranco, M.R.
  9. Bochers, C.H.
  10. Gram, I.T.
  11. Han, J.
  12. Amos, C.I.
  13. Hung, R.J.
  14. Grankvist, K.
  15. Nøst, T.H.
  16. Imaz, L.
  17. Chirlaque-López, M.D.
  18. Johansson, M.
  19. Kaaks, R.
  20. Kühn, T.
  21. Martin, R.M.
  22. McKay, J.D.
  23. Pala, V.
  24. Robbins, H.A.
  25. Sandanger, T.M.
  26. Schibli, D.
  27. Schulze, M.B.
  28. Travis, R.C.
  29. Vineis, P.
  30. Weiderpass, E.
  31. Brennan, P.
  32. Johansson, M.
  33. Richards, J.B.
  34. Montrer des auteurs +
Revue:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

ISSN: 1538-7755

Année de publication: 2022

Volumen: 31

Número: 10

Pages: 1966-1974

Type: Article

DOI: 10.1158/1055-9965.EPI-21-1033 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus